Molecules/RETIFANLIMAB

RETIFANLIMAB

Molecular Identity

AntibodyApprovedFirst approved 2023

Mechanism of action: Programmed cell death protein 1 antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

AEX-1188AEX1188INCMGA-00012INCMGA00012INCMGA-0012MGA-012MGA012RETIFANLIMABRETIFANLIMAB-DLWRZYNYZ

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to RETIFANLIMAB

Loading drug network...